Ramelteon Tablet
Product Images NDC 71335-1853

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ramelteon (NDC 71335-1853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (61413940 2f21 450e 93ef 7689f114932d 01)

Image (61413940 2f21 450e 93ef 7689f114932d 01)
Chemical structure of the active ingredient Ramelteon showing its molecular configuration with labeled functional groups and bonds.*
FDA Label Image

Label (Lbl713351853)

Label (Lbl713351853)
Label for Ramelteon 8 mg tablet, an oral prescription drug packaged by Bryant Ranch Prepack. The label states it is comparable to Rozarem 8 mg tablet by Cadila Healthcare Limited. It indicates a quantity of 30 tablets and storage instructions at room temperature (20°-25°C). The label also includes a barcode and a warning to keep drugs out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.